Cargando…
Quantifying smoking exposure, genomic correlates, and related risk of treatment failure in p16+ squamous cell carcinoma of the oropharynx
OBJECTIVES: HPV‐associated (p16+) squamous cell carcinoma of the oropharynx (OPSCC) has improved survival as compared to HPV‐negative, smoking‐associated disease. Intermediate outcomes have been noted in patients with p16+ tumors and smoking exposure. However, the extent of smoking exposure required...
Autores principales: | Schrank, Travis, Weir, William, Lal, Asim, Landess, Lee, Lenze, Nicholas, Hackman, Trevor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665424/ https://www.ncbi.nlm.nih.gov/pubmed/34938877 http://dx.doi.org/10.1002/lio2.695 |
Ejemplares similares
-
Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma
por: Sheth, Siddharth, et al.
Publicado: (2021) -
A Hidden Epidemic of “Intermediate Risk” Oropharynx Cancer
por: Sandulache, Vlad C., et al.
Publicado: (2019) -
Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
por: Hamill, Chelsea S., et al.
Publicado: (2022) -
Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients
por: Karakullukcu, Baris, et al.
Publicado: (2010) -
Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study
por: Borggreven, Pepijn A., et al.
Publicado: (2007)